Softgel Capsules Market Size to Grow USD 17.19 Billion by 2033

Key Points

• North America led the market with the largest market share of 43% in 2023.
• By type, the gelatin-based/animal-based segment has accounted biggest market share in 2023.
• By application, the vitamins and dietary supplements segment held the largest share of the market in 2023.
• By end-use, the nutraceutical companies segment has contributed more than 38% of market share in 2023.

Softgel capsules, also known as soft gelatin capsules, are a popular form of oral dosage in the pharmaceutical and nutraceutical industries. These capsules are made from gelatin combined with glycerin or sorbitol to create a soft, easy-to-swallow shell. Softgel capsules are utilized for the encapsulation of liquids, suspensions, and semisolids, offering advantages such as enhanced bioavailability, improved stability, and precise dosage delivery. They are widely used for the administration of various pharmaceutical drugs, vitamins, dietary supplements, and herbal remedies. The global softgel capsules market has witnessed significant growth in recent years, driven by increasing consumer demand for convenient and easy-to-swallow dosage forms, as well as advancements in softgel manufacturing technologies.

Get a Sample: https://www.precedenceresearch.com/sample/3929

Growth Factors

Several factors contribute to the growth of the softgel capsules market. Firstly, the rising prevalence of chronic diseases and the growing geriatric population have led to an increased demand for pharmaceutical drugs and dietary supplements, driving the consumption of softgel capsules. Additionally, the expanding nutraceutical industry, coupled with growing consumer awareness regarding preventive healthcare and wellness trends, has spurred the demand for softgel encapsulated supplements and vitamins. Furthermore, technological advancements in softgel manufacturing processes, such as improved formulations, filling techniques, and quality control measures, have enhanced the efficiency and scalability of softgel production, thereby fueling market growth. Moreover, the versatility of softgel capsules in accommodating a wide range of active pharmaceutical ingredients (APIs) and functional ingredients has further expanded their applications across various therapeutic and nutritional sectors, contributing to market expansion.

Region Insights

The softgel capsules market exhibits a global presence, with key regional markets including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a significant share of the market, driven by the presence of established pharmaceutical and nutraceutical industries, as well as a large consumer base inclined towards health and wellness products. In Europe, stringent regulations regarding pharmaceutical quality and safety standards have propelled the adoption of softgel capsules among manufacturers. The Asia Pacific region is poised for substantial growth, attributed to the increasing healthcare expenditure, rising disposable income, and expanding pharmaceutical manufacturing infrastructure in countries such as China, India, and Japan. Latin America and the Middle East and Africa are also witnessing growing demand for softgel capsules, driven by improving healthcare access and rising consumer awareness regarding preventive healthcare practices.

Softgel Capsules Market Scope

Softgel Capsules Market Dynamics

Drivers:

Several key drivers are influencing the growth of the softgel capsules market. Firstly, the convenience and ease of swallowing offered by softgel capsules make them preferred over traditional dosage forms such as tablets and pills, especially among pediatric and geriatric populations. Additionally, the superior bioavailability of softgel encapsulated formulations ensures efficient absorption of active ingredients, leading to improved therapeutic outcomes and patient compliance. Furthermore, the customization capabilities of softgel capsules enable manufacturers to develop tailor-made formulations with precise dosage strengths and controlled release profiles, catering to specific patient needs and therapeutic requirements. Moreover, the growing trend towards self-medication and preventive healthcare has bolstered the demand for over-the-counter (OTC) softgel supplements and vitamins, driving market expansion.

Restraints:

Despite the favorable growth prospects, the softgel capsules market faces certain restraints and challenges. One of the primary concerns is the high manufacturing costs associated with softgel production, attributed to the specialized equipment, raw materials, and stringent quality control requirements involved. Additionally, the sourcing of gelatin, a key component of softgel capsules, from animal-derived sources raises ethical and cultural considerations, leading to the development of alternative formulations such as vegetarian and vegan softgels. Moreover, regulatory compliance and approval processes vary across different geographies, posing challenges for market players in terms of product registration, labeling requirements, and quality assurance standards. Furthermore, the competitive landscape of the softgel capsules market is characterized by the presence of established players and intense competition, which may hinder the market entry of new entrants and small-scale manufacturers.

Opportunities:

Despite the challenges, the softgel capsules market presents several opportunities for growth and innovation. Firstly, the emergence of novel drug delivery technologies and formulations, such as lipid-based drug delivery systems and nanoencapsulation techniques, offers promising avenues for enhancing the therapeutic efficacy and bioavailability of softgel encapsulated drugs. Additionally, the growing trend towards personalized medicine and patient-centric healthcare models creates opportunities for the development of customized softgel formulations tailored to individual patient profiles and treatment regimens. Furthermore, the expanding applications of softgel capsules beyond pharmaceuticals, including in the nutraceutical, cosmeceutical, and veterinary sectors, present lucrative growth opportunities for market players. Moreover, strategic collaborations, partnerships, and mergers and acquisitions can facilitate market expansion and geographical diversification, enabling companies to leverage synergies and strengthen their competitive positions in the global softgel capsules market.

Read Also: Smart Home Healthcare Market Size to Touch USD 212.55 Bn by 2033

Recent Developments

• In May 2022, the launch of SOLFEROL Softgel Capsules, a line of reimbursed vitamin D3 medications, for the treatment of vitamin D insufficiency was announced by Windzor Pharma Ireland Ltd. This product has the broadest array of presentations available on the market, with two distinct strengths: 400 IU for treating expectant and nursing mothers and 20,000 IU for those with severe vitamin D3 deficiency.
• In December 2023, Amneal Pharmaceuticals and Strides Pharma Science Limited announced the launch of Icosapent ethyl acid soft gel capsules, a product that refers VASCEPA. Strides, a multinational pharmaceutical producer, has granted an in-license for the medicine, which Amneal will begin marketing in the fourth quarter of 2023. An ethyl ester of eicosapentaenoic acid (EPA), isicosapent ethyl acid soft gel capsules, 0.5g and 1g, are recommended as a dietary supplement to lower triglyceride levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.

Softgel Capsules Market Players

• CAPTEK Softgel International Inc.
• Sirio Pharma Co., Ltd.
• Fuji Capsule
• Thermo Fisher Scientific Inc.
• EyePoint Pharmaceuticals, Inc.
• EuroCaps
• Catalent, Inc.
• Aenova Group
• ProCaps Laboratories, LLC
• Lonza Capsules & Health Ingredientss
• Soft Gel Technologies, Inc.

Segments Covered in the Report

By Type

• Non-Animal-Based
• Gelatin-Based/Animal-Based

By Application

• Anti-Inflammatory Drugs
• Antacid and Anti-Flatulent Preparation
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Anti-Anemic Preparations
• Vitamin and Dietary Supplement
• Health Supplement
• Pregnancy

By End-use

• Cosmeceutical Companies
• Nutraceutical Companies
• Pharmaceutical Companies
• Contract Manufacturing Organizations

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/